Transfusion and Apheresis Science

Article	Citations
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study	141
Anemia is associated with severe coronavirus disease 2019 (COVID-19) infection	65
Management of blood supply and demand during the COVID-19 pandemic in King Abdullah Hospital, Bisha, Saudi Arabia	63
Inventory management in blood supply chain considering fuzzy supply/demand uncertainties and lateral transshipment	55
Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma	48
Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia	38
CRISPR/Cas9 gene editing for curing sickle cell disease	37
First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia	36
Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine	36
Potential challenges faced by blood bank services during COVID-19 pandemic and their mitigative measures: The Indian scenario	35
COVID-19 and the ABO blood group connection	34
Patient blood management: The best approach to transfusion medicine risk management	34
Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis	33
Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasma	31
Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy	31
Convalescent plasma therapy in patients with COVID-19	30
Systematic review and meta-analysis of the susceptibility of ABO blood group to COVID-19 infection	29
Promoting access to COVID-19 convalescent plasma in low- and middle-income countries	25
SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma	25
SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation	24
Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi, Pakistan	22
The true historical origin of convalescent plasma therapy	22
Convalescent plasma therapy for severe Covid-19 in patients with hematological malignancies	21
Blood shortages and changes to massive transfusion protocols: Survey of hospital practices during the COVID-19 pandemic	18
Umbilical cord blood: Current uses for transfusion and regenerative medicine	18

No transmission of SARS-CoV-2 in a patient undergoing allogeneic hematopoietic cell transplantation from a matched-related donor with unknown COVID-19	18
Feasibility of leukapheresis for CAR T-cell production in heavily pre-treated pediatric patients	18
Two patients with rituximab associated low gammaglobulin levels and relapsed covid-19 infections treated with convalescent plasma	18
Symmetrical peripheral gangrene in critical illness	18
The use of convalescent plasma for pediatric patients with SARS-CoV-2: A systematic literature review	17
Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome	16
Therapeutic plasma exchange (TPE) as a plausible rescue therapy in severe vaccine-induced immune thrombotic thrombocytopenia	15
Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies	14
RhIg for the prevention Rh immunization and IVIg for the treatment of affected neonates	14
Therapeutic plasma exchange in the pediatric intensive care unit: A single-center 5-Year experience	14
Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19	14
Dwindling blood reserves: An ominous downside of COVID-19 pandemic	13
Convalescent plasma therapy in patients with COVID-19	13
Successful management of three patients with autoimmune thrombotic thrombocytopenic purpura with paradigm-changing therapy: Caplacizumab, steroids, plasma exchange, rituximab, and intravenous immunogl	13
Three non-classical mechanisms for anemic disease of the fetus and newborn, based on maternal anti-Kell, anti-Ge3, anti-M, and anti-Jra cases	13
Convalescent plasma to aid in recovery of COVID-19 pneumonia in a child with acute lymphoblastic leukemia	13
Analysis of blood donors’ characteristics and deferrals related to COVID-19 in Iran	12
COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review	12
Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption	12
Unit-to-unit variability in the deformability of red blood cells	12
Therapeutic plasma exchange: A potential management strategy for critically ill MIS-C patients in the pediatric intensive care unit	12
Role of the AB0 blood group in COVID-19 infection and complications: A population-based study	12
Patient blood management implementation in light of new Italian laws on patient's safety	12
Reduced deformability of stored red blood cells is associated with generation of extracellular vesicles	12
Comparison of allogenic stem cell transplantations performed with frozen or fresh stem cell products with regard to GVHD and mortality	12
Emerging insights into the role of albumin with plasma exchange in Alzheimer’s disease management	12
Wound healing effect of autologous fibrin glue and polyglycolic acid sheets in a rat back skin defect model	12
Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation	11
Convalescent plasma from COVID 19 patients enhances intensive care unit survival rate. A preliminary report	11
COVID-19: Further evidence of no transfusion transmission	11
People with blood disorders can be more vulnerable during COVID-19 pandemic: A hypothesis paper	11
Is the Italian consent to transfusion really informed? A medico-legal analysis between old ghosts and new evidence	11
The frequent and the unusual red cell phenotypes in Indian blood donors: A quest for rare donors	11
The role of therapeutic plasmapheresis in patients with hyperthyroidism	11
A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19	10
Immunohematologic aspects of alloimmunization and alloantibody detection: A focus on pregnancy and hemolytic disease of the fetus and newborn	10
Cellular therapy for the treatment of solid tumors	10
SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors	10
Artificial intelligence meets hematology	10
Leukoreduction makes a difference: A pair proteomics study of extracellular vesicles in red blood cell units	10
Peripheral Blood Stem Cell Mobilization and Collection in Pediatric Healthy Sibling Donors Weighing 20 Kilograms or Less; Algerian Experience	10
Knowledge, attitude and practice of blood donation and the role of religious beliefs among health sciences undergraduate students	9
Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?	9
The effect of therapeutic plasma exchange on management of HELLP Syndrome: The report of 47 patients	9
Optimizing pediatric peripheral blood stem cell collection	9
Autoimmune complications of COVID-19 and potential consequences for long-lasting disease syndromes	9
Organization of the outdoor blood donation drives amid novel coronavirus pandemic and national lockdown: An experience from a tertiary care oncology institution in India	9
A look-back at convalescent plasma to treat COVID-19	9
Effects of cell concentration, time of fresh storage, and cryopreservation on peripheral blood stem cells	9
Understanding the demand for phenotyped red blood cell units and requests to perform molecular red blood cell typing for Australian patients	9

Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients	9
Is pathogen reduction an acceptable alternative to irradiation for risk mitigation of transfusion-associated graft versus host disease?	8
Motivators, barriers and communication channels for blood donation in relation to students at a university in Spain	8
Therapeutic plasma exchange in critically ill children: experience of the pediatric intensive care unit of two centers in Chile	8
Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of Turkish hematology research and ed	8
Mesenchymal stromal cells: Getting ready for clinical primetime	8
Assessment of serum iron stores in regular plateletpheresis donors	8
Anti-SARS-CoV-2 hyperimmune plasma workflow	8
Addition of plerixafor to G-CSF in poor mobilizing healthy related donors overcame mobilization failure: An observational case series on behalf of the Grupo Español de Trasplante Hematopoyético (GETH)	8
In vitro platelet production for transfusion purposes: Where are we now?	8
Sickle cell disease in the new era: advances in drug treatment	8
Baseline haemoglobin and thromboelastometry are predictive of red blood cell requirements and one-year mortality in liver transplantation	8
Non-fungible tokens: Stem cell transplantation in the blockchain	8
Mini-review on the properties and possible applications of therapeutic oxygen carrier Hemarina-M101	8
Platelet and extracellular vesicles in COVID-19 infection and its vaccines	7
Spotlight on animal models of acute traumatic coagulopathy: an update	7
ROTEM in the setting of liver transplant surgery reduces frozen plasma transfusion	7
Therapeutic plasma exchange and continuous renal replacement therapy in pediatric dengue-associated acute liver failure: A case series from Vietnam	7
Awareness about Coronavirus (COVID-19) and challenges for blood services among potential blood donors	7
Classification of major and minor blood group antigens in the Kuwaiti Arab population	7
Apoptosis as an underlying mechanism in lymphocytes induced by riboflavin and ultraviolet light	7
Characteristics and causes of pre-donation deferrals at a Chinese blood center	7
The impact of blood campaigns using mobile blood collection drives on blood supply management during the COVID-19 pandemic	7
The successful management of an elderly Covid-19 infected patient by plasmapheresis	7
A comparison of chemo-free strategy with G-CSF plus plerixafor on demand versus intermediate-dose cyclophosphamide and G-CSF as PBSC mobilization in newly diagnosed multiple myeloma patients: An Itali	7
Preoperative plasmapheresis experience in Graves’ disease patients with anti-thyroid drug-induced hepatotoxicity	7
Plasma exchange followed by convalescent plasma transfusion in COVID-19 patients	7
N-acetylcysteine reduce the stress induced by cold storage of platelets: A potential way to extend shelf life of platelets	7
Seroprevalence of SARS-Coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: Implications for safety of blood donors and blood collection staff during bloo	7
Cargo-laden erythrocyte ghosts target liver mediated by macrophages	7
Immunotherapy for COVID-19: Evolving treatment of viral infection and associated adverse immunological reactions	7
Fetal and neonatal allo-immune response	6
Patient blood management and blood conservation – Complimentary concepts and solutions for blood establishments and clinical services in South Africa and beyond	6
Complete neurological recovery from fat embolism syndrome in sickle cell disease after sequential red cell exchange transfusion and therapeutic plasma exchange	6
Remodelling whole blood processing through automation and pathogen reduction technology at the Luxembourg Red Cross	6
Erythrocyte Alloimmunity and Genetic Variance: Results from the Collaborative Study of Alloimmunity to Antigen Diversity in Asian Populations (All ADP)	6
Role of therapeutic plasma exchanges in systemic vasculitis	6
Analysis of ABO grouping discrepancies among patients from a tertiary hospital in Korea	6
Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remission	6
Blood donor deferral periods after COVID-19 vaccination	6
Effectiveness of supplemental oral calcium drink in preventing citrate-related adverse effects in peripheral blood progenitor cell collection	6
The association of ABO blood group with the asymptomatic COVID-19 cases in India	6
Sero-prevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Norway, winter/spring 2021	6
Challenges in platelet inventory management at a tertiary care oncology center during the novel coronavirus disease (COVID-19) pandemic lockdown in India	6
Renal function and the oxidative status among children with thalassemia major and healthy controls: A cross-sectional study	6
SARS-CoV-2 and cancer: the intriguing and informative cross-talk	6
An update on COVID-19 infection control measures, plasma-based therapeutics, corticosteroid pharmacotherapy and vaccine research	6
Gene therapy for hemoglobinopathies	6
Acquired hemophilia A following COVID-19 vaccination – The importance of prompt diagnosis: A case report	6
Early high-titer convalescent plasma therapy in patients with moderate and severe COVID-19	6
Clinical and molecular characterization of Iranian patients with congenital fibrinogen disorders	6
An introductory commentary on the use of artificial intelligence, machine learning and TQM, as novel computational tools in big data patterns or procedural analysis, in transfusion medicine	6
Preparedness and activities of the anti-SARS-CoV-2 convalescent plasma bank in the Veneto region (Italy): An organizational model for future emergencies	6
Blood donation and heavy metal poisoning in developing nations: Any link?	6
Attenuation of age-elevated blood factors by repositioning plasmapheresis: A novel perspective and approach	6
Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia	6
Emerging use of machine learning and advanced technologies to assess red cell quality	6
Transfusion outcome for volume- and plasma-reduced platelet concentrates for pediatric patients	5
Acquired methemoglobinemia: A systematic review of reported cases	5
Transfusion reactions: A retrospective analysis of the Iranian national haemovigilance system (INHS) data	5
Screening for antibodies to HLA class I in apheresis donors following Covid‐19 or SARS-CoV-2 vaccination	5
Platelet supernatant with longer storage inhibits tumor cell growth	5
Metabolomics comparison of cord and peripheral blood-derived serum eye drops for the treatment of dry eye disease	5
COVID-19 antibody donation using immunoadsorption: Report of two cases	5
Plasma exchange and thrombotic microangiopathies: From pathophysiology to clinical practice	5
Effects of ultrasound guided leukocyte-rich platelet-rich plasma (LR-PRP) injection in patients with pes anserinus tendinobursitis	5
Infectious complications in neonatal transfusion: Narrative review and personal contribution	5
Analyses of registry data of patients with anti-GBM and antineutrophil cytoplasmatic antibody-associated (ANCA) vasculitis treated with or without therapeutic apheresis	5
Characterization of circulating and cultured Tfh-like cells in sickle cell disease in relation to red blood cell alloimmunization status	5
Platelet-rich plasma for the treatment of burn wounds: A meta-analysis of randomized controlled trials	5
Use of granulocyte transfusion in early period in life-threatening infections of pediatric hematology and oncology patients: A single-center experience	5
Transfusion practices during the COVID-19 pandemic: An experience from a hematology daycare in India	5
Usefulness of hematopoietic progenitor cell monitoring to predict autologous peripheral blood stem cell harvest timing: A single-center retrospective study	5
RHD genotyping is recommended for all patients with serological weak-D phenotypes in Asian populations – Cases with coexistence of weak-D and Asia type DEL alleles results in complete expression of D-	5
The importance of microbiota in hematology	5
Q fever as a rare cause of hemophagocytic lymphohistiocytosis: Case report	5
Comparative evaluation of ADVIA Centaur® XP chemiluminescence system for screening of HBV, HCV, HIV and syphilis in Indian blood donors	5
Labile iron, ROS, and cell death are prominently induced by haemin, but not by non-transferrin-bound iron	5
Transfusion Camp: Successes and challenges in scaling and expanding a transfusion medicine education program	5
Double filtration plasmapheresis – 10-year pediatric experience as an alternative to plasma exchange	5

Taking therapeutic apheresis services to patients in South Africa: An eight year review of SANBS mobile therapeutic apheresis service, 2013–2020	5
Convalescent plasma therapy in B-cell-depleted and B-cell sufficient patients with life-threatening COVID-19 – A case series	5
Transient elastography of liver: Could it be a guide for diagnosis and management strategy in hepatic veno-occlusive disease (sinusoidal obstruction syndrome)?	5
Hepatitis-associated aplastic anemia in pediatric patients: single center experience	5
Molecular identification of the emerging Human Gemykibivirus-2 (HuGkV-2) among Brazilian blood donors	5
How do I see the production of engineered blood cells available for transfusion?	5
Iatrogenic anaemia and transfusion thresholds in ICU patients with COVID-19 disease at a tertiary care hospital	5
Novel autologous, high concentrated fibrin as advanced hemostatic agent for coronary surgery	5
Convalescent plasma as a treatment modality for coronavirus disease 2019 in Sudan	5
Analysis of extracorporeal photopheresis within the frame of the WAA register	5
Whole blood derived covid convalescent plasma: A practical experience from India	4
Plerixafor combined with G-CSF for stem cell mobilization in children qualified for autologous transplantation- single center experience	4
Platelet number and function alterations in preclinical models of sterile inflammation and sepsis patients: implications in the pathophysiology and treatment of inflammation	4
Early therapeutic plasma exchange may improve treatment outcomes in severe acute toxic Hepatitis	4
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation	4
Survey based cross-sectional study to analyse the variation of practices at blood centres during COVID-19 pandemic in India	4
Transfusion transmitted babesiosis: A systematic review of reported cases	4
Examining participant representation by sex, race, ethnicity and age in United States blood donation and blood transfusion clinical trials	4
Retrospective comparison between non-treponemal and treponemal tests for screening of blood donors for syphilis and their correlation with donor history in a tertiary care teaching hospital	4
Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study	4
PD-1 blockader-associated atypical hemophagocytic lymphohistiocytosis: A cautionary case report	4
Can plasma exchange therapy be an option for the treatment of SARS-CoV-2 Related Splenial Lesion Syndrome: Two cases from the pediatric intensive care unit	4
Identifying the possible causes of recurrent leukodepletion filter blockage in whole blood donations	4
Genotyping of blood groups in alloimmunized patients with β-thalassemia major by T-ARMS-PCR and multiplex-aso-pcr	4
Factors influencing voluntary blood donation practice among university students of Bangladesh	4
Therapeutic plasma exchange in pediatric patients with acute demyelinating syndromes of the central nervous system: A single-center experience	4
Hemolytic anemia and plasma exchange	4
SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment	4
Predictors of poor haematopoietic stem cell mobilisation in patients with haematological malignancies at a South African centre	4
Plasma supply in the United States	4
Trends of Infectious Disease Markers Among Healthy Blood Donors In Northern India: A Ten Year Study	4
Medical student education in transfusion medicine, part II: Moving forward to building up a "Know How" education program in transfusion medicine for under-graduate medical students	4
Bone marrow CD34 positive cells may be suitable for collection after death	4
The rhesus incompatible pregnancy and its consequences for affected fetuses and neonates	4
Secondary alloanti-D immunization post transfusion of “Asia type” DEL red blood cells	4
An Overview of Current Position on Cell Therapy in Transfusion Science and Medicine: From Fictional Promises to Factual and Perspectives from Red Cell Substitution to Stem Cell Therapy	4
Documentation errors in transfusion chain: Challenges and interventions	4
Extracorporeal photopheresis in the treatment of acute and chronic graft-versus-host disease: A position statement from the Turkish Society of Apheresis (TSA)	4
COVID 19 convalescent plasma: Is there still a place for CCP?	4
The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection	4
Complete ADAMTS13 remission in a patient with refractory autoimmune-mediated thrombotic thrombocytopenic purpura after infliximab	4
Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico	4
Blood transfusion trends by disease category in the United States, 2000 to 2014	4
Is it necessary to add the eluate testing to the direct antiglobulin test to improve the detection of maternal erythrocyte alloantibodies?	4
Thrombin Generation in a patient with Triple Positive Antiphospholipid Syndrome Treated with Three Different Anticoagulants	4
Basic principles of therapeutic plasma exchange	4
Impact of COVID-19 pandemic in the activity of a Therapeutic Apheresis unit in Italy	4
Successful autologous peripheral blood stem cell collection using large volume leukapheresis in patients with very low or undetectable peripheral blood CD34+ progenitor cells	4
Evaluation of patients diagnosed with psoriasis and multiple myeloma after autologous stem cell transplantation	4
Trends and targets of various types of stem cell derived transfusable RBC substitution therapy: Obstacles that need to be converted to opportunity	4
Plerixafor strategies for autologous hematopoietic cell transplant mobilization: A comparison of efficacy and cost	4
Real-world data of the use and experience of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura: Case series	4
Engraftment after autologous hematopoietic stem cell transplantation in patients mobilized with Plerixafor: A retrospective, multicenter study of a large series of patients	4
Seroprevalence of SARS-CoV-2 IgG antibody among healthy blood donors: a single centre study	4
COVID-19-associated Evans syndrome: A case report and review of the literature	4
Blood supply management during the Covid-19 pandemic: Experience in a tertiary referral hospital in Malaysia	4
Donor safety in an individualized plasmapheresis program – Results of an interim analysis	4
Changes in blood donation and utilization secondary to Covid-19 outbreak	4
Perceptions and practices of the Brazilian LGBT+ population toward blood donation	4
Investigating the production of platelet lysate obtained from low volume Cord Blood Units: Focus on growth factor content and regenerative potential	4
Thrombocytopenia due to rivaroxaban: A rare adverse effect	4
Blood donors, iron deficiency and supplementation options – Will clinical trials help moving forward?	3
Plasmapheresis in ABO incompatible kidney transplant	3
Retrospective analysis of direct antiglobulin test positivity at tertiary academic hospital over 10 years	3
A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma	3
How is transfusion-associated graft-versus-host disease similar to, yet different from, organ transplantation-associated graft-versus-host disease?	3
Regulatory consideration on preparation and clinical use of COVID-19 convalescent plasma	3
Efficacy and safety of plasmapheresis in symptomatic hyperviscosity and cast nephropathy: A Multicenter Experience in Turkey	3
Human placenta-derived mesenchymal stromal cells transfusion in a critically Ill infant diagnosed with Coronavirus Disease 2019 (COVID-19): A case report	3
Transfusion-associated babesiosis in China: A case report	3
Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma	3
Title: Effect of multiple maternal red cell alloantibodies on the occurrence and severity of Hemolytic Disease of the Fetus and Newborn	3
Polyclonal immunoglobulins for COVID-19 pre-exposure prophylaxis in immunocompromised patients	3
Hepcidin as a diagnostic marker of iron deficiency in blood donors	3
Pancytopenia in a newborn due to maternal piperacillin and human leukocyte antigen antibodies	3
Low-dose cyclophosphamide and granulocyte colony-stimulating factor are sufficient for peripheral blood stem cell mobilization in patients with multiple myeloma	3
Clinical and immunohematological characterization of autoimmune hemolytic anemia in children	3
Process capability indexes: Trends and developments in the manufacturing of blood components	3
Identifying correlations between donor demographics and isohemagglutinin titers as a potential method to screen for low-titer group O whole blood	3
Reduced volume of red blood cell priming is safe for pediatric patients undergoing therapeutic plasma exchange	3
The apheresis content analysis in Allo-HSCT represents reliable influential factors on graft-versus-host disease and overall survival	3
Impact of HLA-G +3142C>G on the development of antibodies to blood group systems other than the Rh and Kell among sensitized patients with sickle cell disease	3
Utilization of emicizumab in acquired hemophilia A: A case report	3
Therapeutic plasma exchange for envenomation: Is it reasonable?	3
The D-dimer reference intervals in healty term newborns	3
Seroepidemiology of Toxoplasma gondii in blood donors in Portugal	3
The secrets of human stem cell-derived transfusable RBC for targeted large-scale production and clinical applications: A fresh look into what we need most and lessons to be learned	3
The effect of a viscoelastic-guided bleeding algorithm implementation on blood products use in adult liver transplant patients. A propensity score-matched before-after study	3
Leukapheresis for CAR-T cell production and therapy	3
Anti-A and anti-A,B monoclonal antisera with high titers favor the detection of A weak phenotypes	3
Benford’s law and metabolomics: A tale of numbers and blood	3
Idiopathic TTP in the Middle East: Epidemiology and clinical outcomes in infection associated episodes	3
DMSO (Me2SO) concentrations of 1-2% in combination with pentaisomaltose are effective for cryopreservation of T cells	3
Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma - Single center experience	3
Urgent therapeutic plasma exchange	3